KAPA (Kairos Pharma) FFO


KAPA Kairos Pharma Ltd KAPA
15 GF Score
Price $0.38
View Full Analysis

What is Kairos Pharma FFO?

FFO (Funds from operations) only applies to REITs.

KAPA
15GF Score
Kairos Pharma Ltd KAPA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kairos Pharma Business Description

Address 2355 Westwood Boulevard, No. 139, Los Angeles, CA, USA, 90064
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
15GF Score

Get the complete analysis for KAPA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.38
Price